- Home
- TRMB vs BMRN Comparison
TRMB vs BMRN Comparison
Compare TRMB & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRMB | BMRN |
|---|---|---|
| Founded | 1978 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 11.4B |
| IPO Year | 1996 | 1999 |
Fundamental Metrics
Financial Performance| Metric | TRMB | BMRN |
|---|---|---|
| Price | $56.38 | $66.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | ★ $93.50 | $88.22 |
| AVG Volume (30 Days) | ★ 2.7M | 2.2M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | ★ $3,798,700,000.00 | $1,313,646,000.00 |
| Revenue This Year | $9.92 | $15.02 |
| Revenue Next Year | $8.04 | $12.23 |
| P/E Ratio | ★ N/A | $87.48 |
| Revenue Growth | 3.33 | ★ 17.62 |
| 52 Week Low | $47.92 | $49.26 |
| 52 Week High | $84.42 | $70.98 |
Technical Indicators
Market Signals| Indicator | TRMB | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 64.94 |
| Support Level | $49.37 | $58.03 |
| Resistance Level | $59.18 | N/A |
| Average True Range (ATR) | 2.20 | 2.04 |
| MACD | -0.22 | 0.54 |
| Stochastic Oscillator | 18.93 | 67.91 |
Price Performance
Historical ComparisonAbout TRMB Trimble Inc.
Trimble Inc is a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has three reportable segments: Architects, Engineers, Construction, and Owners (AECO). This segment provides software solutions that sell through a direct channel to customers in the construction industry. Field Systems. This segment provides hardware and associated software solutions that sell through dealer partner channels. Transportation and Logistics (T&L). This segment provides solutions for customers working in long-haul trucking and freight shipping markets.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.